Highlight 
 
 
 
 
 
 
   
 
 
 
 
   
www.vanefist.eu
HEALTH 2005, July 13
 
Biocydex and BioXtract move forward hand in hand
 

 
Biocydex has just concluded a partnership agreement with BioXtract, its Walloon alter ego. For Yves Ceatiempo and Mustapha Belgsir, the directors of the fledgling scientific start-up of the Poitiers Biopole, this is a deal made in heaven.

Nine salaried employees, three years of existence, similar university beginnings... Except for the accent, nothing really distinguishes the respective directorships of Biocydex and BioXtract. And in fact, these two human-sized businesses in the health field rapidly realized that they were truly on the same wave length. They also share another appreciable common point, which is that they both belong to networks: on the one hand the Poitiers Biopole, and on the other hand the (Walloon-based) Namur Agrobiopole. “We met for the first time in October 2004 at the initiative of the CAP (of Greater Poitiers)”, recalls Mustapha Belgsir, the general manager of the Poitiers-based scientific start-up enterprise. The Biopole had brought along a delegation composed of firms, and Biocydex was one of them.

Having been placed in contact with each other, the two structures carried on their discussions prior to signing their partnership agreement this past April. “We are specialized in the selection, the extraction and the formulation of plant-based ingredients”, specifies Fabien Priem, the general manager of BioXtract, of which the domains of predilection are pharmacy, phytotherapy and the food processing industry. “We were looking for a partner able to render our products soluble and enhance their active principles”. And a partner is exactly what the Walloon-based company found; the specialty of its Poitiers-based counterpart is... solubilizing molecules and optimizing their active principles!

An anti-inflammatory product

Following a “conclusive” initial phase of testing, the two partners are planning to pursue their collaboration over the coming months. They should once again be communicating hand in hand on the occasion of the issuance of the first product stemming from the work they will have done together. “It is an anti-inflammatory product that will be on the market by the first quarter of 2006 at the latest”, adds Fabien Priem. France, Great Britain, the United States and northern Europe are the first countries or regions slated to proceed to commercialization.

As regards “the affair”, Catherine Coutelle is by no means the last official to rejoice. The vice president of the CAP in charge of economic activities is proud of the fact that it was thanks to a delegation shepherded by Greater Poitiers that Biocydex came into contact with its new Belgian partner. “It goes to show that the international networking policy is reaping fruit”. What is more, other Biopole structures such as Géniflore, Isoclin and Valagro may well be next in line to sign commercial agreements with their Belgian counterparts.

Hospital of Poitiers: The new emergency area is open
 
Home-based hospitalization: A unit comes into being
 
The Poitiers Biopole in the Walloon area of Belgium
 
Health for breakfast
 



BIOalternatives diversifies its markets
read...
 
Two Poitiers-based projects awarded
read...
 
IUT pores over biofuels
read...
 
Poitiers, the biotechnology capital
read...
 
PAREXEL wagers on the human factor
read...
 
Saunier and associates wish to diversify
read...
 
Biocydex and BioXtract move forward hand in hand
read...
 
The grass of champions
read...
 
Ianesco steadfastly believes in its future
read...
 
A tumorotheque, what is the purpose it serves?
read...
 
TechnAvOx has turned the corner
read...
 
Larime is aiming for 40 beds in Poitiers
read...
 
Poitiers is out to promote its research
read...
 
A true Biopole milestone
read...
 
A regional cancerology pole in the pipeline for 2007
read...
 
Nobel prize winners in Poitiers
read...
 
A platform offering numerous advantages
read...
 
@rtMolecule fashions in its own way
read...
 
It’s plastic, it’s fantastic
read...
 
The Poitiers hospital (CHU) stakes its claim
read...
 
BIOalternatives exports its know-how
read...
 
The physiological and computer science engineering program turns 30
read...
 
The Biopole takes center stage at Investiga
read...
 
 
   
  Legal mentions
English / Anglais Français / French